Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery

International Journal of Pharmaceutics

Volumn 298, Issue 2, 2005, Pages 339-343

  Martin, C ^a   Thongborisute, J ^b   Takeuchi, H ^b   Yamamoto, H ^b   Kawashima, Y ^b   Alpar, H O ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bile salts; Cholesterol; Vaccine delivery

Indexed keywords

CHOLIC ACID; DEOXYCHOLATE SODIUM; VACCINE;

ATOMIC FORCE MICROSCOPY; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; MACROMOLECULE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BILE ACIDS AND SALTS; CHOLESTEROL; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FLUORESCEIN-5-ISOTHIOCYANATE; INSULIN; MICELLES; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; VACCINES; VEHICLES;

EID: 21344455951     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.03.038     Document Type: Conference Paper

References (15)

1. Y. Barenholz Liposome application: problems and prospects Curr. Opin. Colloid Interf. Sci. 6 2001 66 77
2. R.H. Bisby Lyotropic liquid crystals E. Wyn-Jones J. Gormally Aggregation Processes in Solution 1982 Elsevier Science Publishing Co. Inc
3. D.J. Brayden Oral vaccination in man using antigens in particles: current status Eur. J. Pharm. Sci. 14 2001 183 189
4. P.R. Cullis, and M.J. Hope Physical properties and functional roles of lipids in membranes D.E. Vance J.E. Vance Biochemistry of Lipids, Lipoproteins and Membranes 1991 Elsevier Science Publishing Co. Inc
5. G. Gregoriadis Engineering liposomes for drug delivery: progress and problems Trends Biotechnol. 13 1995 527 537
6. M. Kokkona, P. Kallinteri, D. Fatouros, and S.G. Antimisiaris Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition Eur. J. Pharm. Sci. 9 2000 245 252
7. C. Martin, J. Thongborisute, H. Takeuchi, H. Yamamoto, Y. Kawashima, and H.O. Alpar Investigation of the interactions between cholesterol and bile salts Proc. Int. Symp. Cont. Rel. Bioact. Mater. 31 2003 288
8. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
9. P.K. Narain, E.J. DeMaria, and D.M. Heuman Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts J. Surg. Res. 84 1999 112 119
10. N.A. Peppas, P. Bures, W. Leobandung, and H. Ichikawa Hydrogels in pharmaceutical formulations Eur. J. Pharm. Biopharm. 50 2000 27 46
11. G.J. Russell-Jones Oral vaccine delivery J. Control. Release 65 2000 49 54
12. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
13. N.G. Venneman, S.J. Huisman, A. Moschetta, G.P. vanBerge-Henegouwen, and K.J. van Erpecum Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallisation in model biles Biochim. Biophys. Acta 1583 2002 221 228
14. M. Wacker, and R. Schubert From mixed micelles to liposomes: critical steps during detergent removal by membrane dialysis Int. J. Pharm. 162 1998 171 175
15. W. Wang Oral protein drug delivery J. Drug Target. 4 1996 195 232